IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q4 2017 Holdings

Filed 2018-02-14 | 16 holdings | $213.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$93.0K4,104,14043.5%
Edge Therapeutics IncCOM279870109$22.0K2,344,86810.3%
Irhythm Technologies Inc(IRTC)COM450056106$18.4K328,7418.6%
Wave Life Sciences LTD(WVE)SHSY95308105$16.1K458,2597.5%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$11.9K507,7305.6%
Oxford Immunotec Global PLCORD SHSG6855A103$11.9K852,4975.6%
Sierra Oncology IncCOM82640U107$10.4K2,798,2244.9%
Obseva SACOMH5861P103$8.7K890,5014.1%
Sage Therapeutics Inc(SG7)COM78667J108$4.1K25,0001.9%
Reshape Lifesciences IncCOM761123108$3.8K2,600,9001.8%
Marinus Pharmaceuticals IncCOM56854Q101$3.5K425,0001.6%
Trillium Therapeutics IncCOM NEW89620X506$2.9K404,1591.4%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.7K964,5201.3%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$2.0K171,3640.9%
Dermira Inc(DERMEUR)COM24983L104$1.7K61,1090.8%
Otonomy IncCOM68906L105$610109,8250.3%